FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Evoq Remedies IPO.
June 7, 2024 2:30:00 PM
Just a few days after Rapport Therapeutics revealed plans for a $122 million IPO, the epilepsy biotech has unveiled an upsized $154 million offering. The Third Rock company�s IPO consists of 8 ...
Published by : FierceBiotechJune 10, 2024 10:20:00 PM
Media network Newsmax plans to publicly list its shares later this year and is looking to raise capital beforehand via a private placement. Boca Raton, Fla.-based Newsmax said Monday in an ...
Published by : Wall Street JournalJune 5, 2024 2:28:00 PM
Telix anticipates the net proceeds from the IPO to be around $183 million, or $211 million if the underwriters� option is exercised in full, according to Securities and Exchange Commission ...
Published by : FierceBiotechJune 17, 2024 3:30:00 AM
Web comics are more than a fun diversion for people as they go about their online day. For Webtoon Entertainment, one of the top online platforms for comics, they could soon be worth hundreds of ...
Published by : Fast CompanyJune 12, 2024 7:17:00 PM
CrowdStrike marks the 5-year anniversay of its IPO with significant milestones and momentum and ... [+] being added to the S&P 500. As CrowdStrike marks the fifth anniversary of its IPO ...
Published by : ForbesJune 11, 2024 5:21:00 PM
Shares in Rumble, a conservative alternative to YouTube that went public in 2022, are up more than 33% year-to-date, but are down 40% overall since its IPO. Shares in Public Sq., a sales ...
Published by : MSNJune 6, 2024 3:30:00 AM
It will only receive the proceeds of the 3,703,704 it is offering directly. That means, at a $27 IPO price, Life360 will raise about $100 million in its IPO. What will Life360 do with the money?
Published by : Fast CompanyJune 7, 2024 1:53:00 AM
The IPO of 45 million shares was priced at $21.50 a share, Waystar said. The pricing, which was in the middle of its indicated range, gives Waystar a fully diluted valuation of $3.69 billion.
Published by : ReutersJune 11, 2024 7:16:00 AM
An OpenAI representative said Friar�s hiring didn�t mean it was planning an IPO. Rather, the representative said, the company had reached a point where it was necessary to have an executive ...
Published by : MarketWatchJune 9, 2024 3:30:00 AM
And now 15 months later, Bajpai and ixigo are once again on the cusp of the IPO. This time around though there�s no hitting the brakes like in 2021. The ixigo IPO opens tomorrow morning and with ...
Published by : inc42The IPO Shares of Evoq Remedies Limited IPO are proposed to list on Wednesday, March 30, 2022 at BSE SME. The public issue of Evoq Remedies IPO was opened on Mar 17, 2022 and closed for subscription on Mar 22, 2022. Evoq Remedies IPO Listing Date and Information:
Listing Date | Wednesday, March 30, 2022 |
BSE Script Code | 543500 |
NSE Symbol | |
Listing In | MT Group of Securities |
ISIN | INE0JVD01011 |
Issue Price | ₹27 Per Equity Share |
Face Value | ₹10 Per Equity Share |
The allotment status of Evoq Remedies Limited IPO is now available online. The public issue of Evoq Remedies IPO was open on Mar 17, 2022 and closed for subscription on Mar 22, 2022. The equity shares of the company to be list at BSE SME.
Evoq Remedies Limited is entering in the capital market with an IPO of 3,600,000 Equity Shares of Rs 10 aggregating up to Rs 9.72 Crore. The price for the issue has been set at Rs 27 Per Equity Share.
Incorporated in 2010, EVOQ Remedies Limited specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices. The company procures all the products from WHO-GMP certified & reliable Manufacturers & Importers, who follow procedures as per the stringent national and international quality and safety standards.
The issue opens on Mar 17, 2022 and closes for subscription on Mar 22, 2022. The equity shares of the company to be list at BSE SME.
The issue of Evoq Remedies Limited opens on Mar 17, 2022 and closes for subscription on Mar 22, 2022. The equity shares of the company to be list at BSE SME. The price for the issue has been set at Rs 27 Per Equity Share.
The Evoq Remedies IPO is proposed to open on March 17, 2022. The IPO application ends on March 22, 2022.
Retail investors can apply in the retail or non-institutional investor category from March 17, 2022 to March 22, 2022. The Evoq Remedies IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Evoq Remedies IPO will open for subscription on March 17, 2022. The public issue will close on March 22, 2022.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|